Cargando…
Application of an iPSC‐Derived Organoid Model for Localized Scleroderma Therapy (Adv. Sci. 16/2022)
Localized Scleroderma Therapy Human‐induced pluripotent stem cell (hiPSC)‐derived epithelial and mesenchymal (EM) organoids can be used to investigate the therapeutic potential for the recovery of localized scleroderma (LoS) associated phenotypes and skin‐associated functions. In article number 2106...
Autores principales: | Ma, Jie, Li, Wei, Cao, Ruiyuan, Gao, Dunqin, Zhang, Qiyu, Li, Xiao, Li, Biyou, Lv, Luye, Li, Mansheng, Jiang, Junyi, Wang, Yujie, Li, Jun, Wu, Zhihong, Zhu, Yunping, Zhong, Wu, Zhang, Shuyang, Leng, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165512/ http://dx.doi.org/10.1002/advs.202270104 |
Ejemplares similares
-
Application of an iPSC‐Derived Organoid Model for Localized Scleroderma Therapy
por: Ma, Jie, et al.
Publicado: (2022) -
Quantifying Wetting Dynamics with Triboelectrification (Adv. Sci. 24/2022)
por: Zhang, Xiaolong, et al.
Publicado: (2022) -
Ocular Nanomedicine (Adv. Sci. 15/2022)
por: Tang, Zhimin, et al.
Publicado: (2022) -
Efficient Mining of Anticancer Peptides from Gut Metagenome (Adv. Sci. 25/2023)
por: Ma, Yue, et al.
Publicado: (2023) -
Programming Crystallographic Orientation in Additive‐Manufactured Beta‐Type Titanium Alloy (Adv. Sci. 28/2023)
por: Luo, Xuan, et al.
Publicado: (2023)